Compare Research Peptides.
Put any research peptides side by side โ mechanism, receptor target, research focus, molecular weight, solubility and pricing, drawn from our HPLC batch-verified compound data. Pick up to four compounds to build your own comparison.
โ Reference tool for in vitro research use only. Summaries describe preclinical laboratory research and imply no human or veterinary use, and provide no dosing, medical or efficacy guidance.
โ swipe the table sideways to see every column โ
Popular head-to-head comparisons
Prefer a written breakdown? These research guides compare two or three compounds in depth โ mechanism, receptor pharmacology and published trial data.
Retatrutide vs Tirzepatide vs SemaglutideTriple agonist vs dual agonist vs single GLP-1, by receptor target and trial data.
BPC-157 vs TB-500Two repair-research peptides: angiogenesis/GI protection vs actin-driven cell migration.
GHK-Cu vs BPC-157Copper-tripeptide remodelling vs pentadecapeptide angiogenic repair.
Retatrutide vs OzempicTriple GLP-1/GIP/glucagon agonism vs single GLP-1 (semaglutide).
Retatrutide vs WegovyTriple-agonist mechanism versus single-receptor semaglutide.
CJC-1295 vs TesamorelinShort-acting GHRH(1-29) vs stabilised full-length GHRH analogue.
Semax vs SelankBDNF/NGF neurotrophic signalling vs GABAergic anxiolytic modulation.
Selank vs DSIPGABA/BDNF anxiolytic pathways vs delta-wave sleep modulation.
Molecular weight, solubility and purity figures are drawn from batch-verified product data for compounds Velox Peptides supplies; other compounds are included for research reference. Pricing shown is the current storefront price for the base research quantity and may vary by size. All compounds are supplied strictly as research reagents for in vitro laboratory use only โ not medicines, and not for human or veterinary use. See our research-use policy.